Division of Nephrology, Mayo Clinic, Phoenix, Arizona.
Division of Nephrology and Hypertension, Mayo Clinic, and William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, Minnesota.
Kidney360. 2024 Nov 1;5(11):1763-1770. doi: 10.34067/KID.0000000579. Epub 2024 Sep 16.
The Hispanic population of the United States is the second largest racial or ethnic group, comprising 18.7% of the population. However, this population is incredibly heterogeneous differing in genetic traits, cultural upbringing, educational backgrounds, and financial status. The impact of this heterogeneity on the prevalence and outcomes of renal disease and kidney transplantation is understudied compared with non-Hispanic White and Black populations. What is known appears to be underrecognized. This review aims to critically assess current medical literature on Hispanic individuals, focusing on etiological factors, disease progression, and outcomes related to CKD and kidney transplantation. By doing so, we aim to underscore key areas for further in-depth investigation.
美国的西班牙裔人口是第二大种族或族群,占人口的 18.7%。然而,这一人群具有令人难以置信的异质性,在遗传特征、文化背景、教育背景和经济地位方面存在差异。与非西班牙裔白人和黑人群体相比,这种异质性对肾脏疾病和肾脏移植的患病率和结局的影响研究不足。已知的情况似乎没有得到充分认识。本综述旨在批判性地评估目前关于西班牙裔个体的医学文献,重点关注与 CKD 和肾脏移植相关的病因因素、疾病进展和结局。通过这样做,我们旨在强调进一步深入研究的关键领域。